COVID-Associated Pulmonary Aspergillosis in the United States: Is It Rare or Have We Missed the Diagnosis?

Sean X Zhang; Joan-Miquel Balada-Llasat; Preeti Pancholi; Kaede V Sullivan; Stefan Riedel; Fungal Diagnostic Laboratories Consortium (FDLC)

doi:10.1128/JCM.01135-21

COVID-Associated Pulmonary Aspergillosis in the United States: Is It Rare or Have We Missed the Diagnosis?

J Clin Microbiol. 2021 Sep 20;59(10):e0113521. doi: 10.1128/JCM.01135-21. Epub 2021 Jul 21.

Authors

Sean X Zhang¹, Joan-Miquel Balada-Llasat², Preeti Pancholi², Kaede V Sullivan³, Stefan Riedel⁴; Fungal Diagnostic Laboratories Consortium (FDLC)

Affiliations

¹ Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
² Department of Pathology, The Ohio State University Wexner Medical Centergrid.412332.5, Columbus, Ohio, USA.
³ Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine at Temple University, Temple University Heath System, Philadelphia, Pennsylvania, USA.
⁴ Clinical Microbiology Laboratories, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Keywords: Aspergillus; COVID-19; aspergillosis; beta-d-glucan; bronchoalveolar lavage; fungal diagnostics; fungal infection; galactomannan; pulmonary aspergillosis.

Publication types

Letter

MeSH terms

COVID-19*
Humans
Invasive Pulmonary Aspergillosis* / diagnosis
Pulmonary Aspergillosis* / diagnosis
Pulmonary Aspergillosis* / epidemiology
SARS-CoV-2
United States / epidemiology